Narayana Hrudayalaya Ltd Share Price

Overview

Narayana Hrudayalaya Ltd share price is currently ₹1,863.37, down by - ₹11.20 (0.6%) from its previous closing price of ₹1,874.57. The share price has gained 1.5% over the past month and gained 4.14% over the past year. The stock's 52-week low and high are ₹1,562.32 and ₹2,082.15, respectively. Narayana Hrudayalaya Ltd has a market capitalisation of ₹ 37,750.00 Cr. The share price was last updated on 09 Sep 2026, 11:52 AM IST.

Narayana Hrudayalaya Ltd
Narayana Hrudayalaya Ltd
NH
 0.00
- 11.20
0.60%
Healthcare
 0.00(%)1D

Updated: 09 Sep 2026, 11:52:03 am IST

Market Data

Open Price

 1,875.37

Prev. Close

 1,874.57
 1,847.11

Day Low

 1,885.22

Day High

 1,562.32

52 Week Low

 2,082.15

52 Week High

HealthcareHospital & Healthcare Services
CategoryLarge Cap

Fundamentals

Quick Bite

Price To Earnings Ratio

46.65

Sector PE

42.03

PB Ratio

8.39

Sector PB

5.73

EPS

39.94

Dividend Yield

0.28

Today's Volume

61.119 K

5 Day Avg. Volume

169.221 K

PEG Ratio

23.92

Market Cap.

₹ 37,750.00 Cr.

StockGro Trade views

Technical Analysis

Forecasts 🧭

Financials

Corporate Actions

ActionsEx-DateRecord-Date
DividendsFinal Dividend of 45% at ₹4.5/Share
17-Jul-202617-Jul-2026
DividendsFinal Dividend of 45% at ₹4.5/Share
01-Aug-202501-Aug-2025

Mutual Fund Ownership

Mutual Fund Holder
Jul 26
Shares held
Aug 26
Shares held
Quantum ESG Best In Class Strategy Fund - Growth - Direct Plan9.28 k
9.28 k
no change
UTI Nifty Midsmallcap 400 Momentum Quality 100 Index Fund - Regular Plan - Growth2.49 k
2.54 k
(2.37%)
UTI Nifty 500 Index Fund - Regular Plan - Growth-
379
(100%)
UTI Nifty 500 ETF-
32
(100%)
Zerodha Nifty Smallcap 100 ETF5.14 k
-
(100%)

About Narayana Hrudayalaya Ltd 👋

Narayana Hrudayalaya Limited is engaged in medical and healthcare services. The Company operates a network of multispecialty and super-specialty hospitals across multiple locations. Its operating segment is Medical and Healthcare Related Services. Its medical services include anesthesiology, audiology, breast oncology and oncoplastic surgery, clinical psychology, congenital adult heart disease, cardiac sciences, developmental and behavioral pediatrics, endocrinology and diabetology, gastrointestinal oncology, gynecologic oncology, hepatology and liver transplantation, interventional and endovascular radiology, medical gastroenterology, neuro rehabilitation, pediatric hematology oncology, speech and swallow rehabilitation, thoracic and vascular surgery, vascular and endovascular surgery, surgical gastroenterology, and surgical oncology, among others. It has a network of over 18 hospitals and three heart centers across India, along with an international presence in the Cayman Islands.

Expert Opinions

Insights from SEBI-registered analysts · updated live

Explore all →
MBA Investmentwala

MBA Investmentwala

30 Aug • 9:25 AM · SEBI-Registered Analyst

EMS Secures ₹20 Crore NHAI Order for User Fee Collection

EMSLIMITED
Order Highlights: EMS has received a Letter of Award (LOA) from NHAI for engagement as a User Fee Agency at the Bartana Fee Plaza in Haryana. The order value is approximately ₹19.91 crore, excluding TCS. The contract relates to the Jind–Gohana Greenfield section of NH-352A. The project is scheduled to be executed over a period of one year. Business Significance: The order provides additional near-term revenue visibility for EMS. It marks participation in user-fee collection operations alongside the company's core infrastructure and water-management projects. Timely execution and efficient management of the contract will be important for the overall financial impact. Key Takeaway: The ₹20 crore NHAI order is a positive development for EMS, adding to its project pipeline and diversifying its revenue opportunities. Continued order inflows and execution of existing projects will remain key factors to watch. Disclaimer: This content is for educational and informational purposes only and should not be considered investment advice or a recommendation to buy or sell any security. Investors should conduct their own research and consider their risk profile before making any investment decision.

See More
Sanjay Ahuja

Sanjay Ahuja

21 Aug • 5:57 PM · SEBI-Registered Analyst

CEIGALL INDIA JVs HAVE SECURED ORDERS FOR ROAD CONSTRUCTION

Infrastructure development company

CEIGALL
joint ventures have secured five Letters of Acceptance (LOAs) from the Ministry of Road Transport & Highways (MoRTH) worth Rs 2,423.70 crore for road construction on NH-913 (Frontier Highway) in Arunachal Pradesh. Together, these five orders span nearly 278 km of Intermediate lane road construction across some of the region's most demanding terrain. These orders will further strengthen the company's order book and reinforce it's strategy of expanding it's geographical presence and diversifying it's infrastructure portfolio across high-potential markets, including it's growing role in the development of critical road infrastructure across the Northeast.

See More
Pankaj pawar

Pankaj pawar

20 Aug • 8:51 AM · SEBI-Registered Analyst

JISLJALEQS

**Stocks in Focus** **

JISLJALEQS
:** Jain Irrigation SystemsCRISIL reaffirmed its **BBB-/Negative** long-term and **A3** short-term ratings, with refinancing of **₹652 crore debt due in FY27** remaining a key concern. **Impact:** **Negative;** refinancing requirements and the negative outlook may keep pressure on investor sentiment. ** !Hyundai Motor India:** Announced a **portfolio-wide price hike of up to 1%** from **September 2026** to offset rising input, commodity and operational costs. **Impact:** **Positive;** the price increase can help offset cost inflation and protect margins. ** !Ceigall India :** Secured its **fifth LOA worth ₹274 crore** for the **Frontier Highway (NH-913)**, taking total wins to **₹2,423.70 crore** over two days for **278 km** of road construction in Arunachal Pradesh. **Impact:** **Strongly Positive;** robust order inflows significantly strengthen the order book and provide strong revenue visibility.

See More
RAJIV GUPTA (SEBI RA)

RAJIV GUPTA (SEBI RA)

19 Aug • 5:47 PM · SEBI-Registered Analyst

Strengthens Order Book with Fifth Win of Rs 274 Crore - Ceigall India Ltd

Code BSE: 544223 NSE:

CEIGALL
Five LOAs, INR 2,423 Cr. in Two Days: Ceigall India Strengthens Order Book with Fifth Win of INR 274 Crore in Arunachal Pradesh a) Rs 274.08 crore LOA for Package-2 of the Bile-Migging section awarded to the Ceigall IndiaRajinder Infrastructure JV, a day after four LOAs worth Rs 2,149.62 crore were awarded to the Ceigall India-Sushee Infra Mining JV for other sections of the same highway b) Fifth LOA on NH-913 (Frontier Highway) received, taking the Company's cumulative wins on the corridor in two days to Rs 2,423.70 crore c) The five packages together span approximately 278 km of Intermediate Lane road construction on one of the Northeast's most strategically important corridors

See More
Pyrifera Investment Advisors

Pyrifera Investment Advisors

19 Aug • 2:17 AM · SEBI-Registered Analyst

EMS Limited Secures ~₹42 Crore NHAI Order; Execution Capacity Remains Key Focus

EMS Limited has emerged as the highest bidder for a confirmed work order valued at ₹4,221.83 lakh (~₹42.2 crore) from the National Highways Authority of India (NHAI). The 1-year contract involves User Fee Agency services for toll plazas in Assam (NH-37) and Haryana (NH-352A). Key Financial & Operational Highlights: Q1 FY27 Recovery: The company reported a sequential improvement in Q1 FY27 with revenue at ₹159.40 crore, Net Profit at ₹15.50 crore, and an Operating Profit Margin (OPM) of 16.56%, recovering from a weak Q4 FY26. Strong Balance Sheet: The company maintains robust liquidity (Current Ratio: 5.14x), minimal leverage (Total Liabilities/Equity: 0.26x), and positive operating cash flows (₹33.50 crore in FY25). Valuation: Market capitalization stands at ~₹2,086 crore, trading at a P/E of 29.9x against a healthy ROCE of 23.98%. Strategic Outlook & Key Risks: Execution Bottleneck: Despite sustained order inflows, the company’s disclosed order book is exceptionally large (covering over 1,180 quarters of average revenue). Consequently, execution capacity, rather than order acquisition, is the primary constraint on near-term revenue growth. Divergence Warning: Annual revenue declined by 25.4% in FY26 despite heavy order wins, highlighting a lag in project execution or revenue recognition. What to Watch: Investors should monitor the company’s ability to accelerate quarterly revenue run-rates, sustain OPM above 15%, manage heavy client concentration (primarily UP Jal Nigam), and ensure positive cash conversion as project volumes scale.

EMSLIMITED

See More
InvestAce Capital

InvestAce Capital

11 Aug • 9:34 AM · SEBI-Registered Analyst

A Korean Financial Giant Just Bought Into an Indian Wealth Platform.

CHOICEIN
is quietly becoming more than a traditional broking business. NH Investment & Securities of South Korea has committed nearly ₹900 crore into Choice's broking subsidiary, while Choice has also received SEBI approval to launch a Category II AIF. Separately, its subsidiaries secured ₹191 crore of government mandates in Q1 FY27. Three different businesses, one emerging platform: broking, alternative investments and government-led digital transformation. Choice International is becoming an interesting financial-services optionality play.

See More

Frequently Asked Questions

What is the share price of Narayana Hrudayalaya Ltd?

What is the market cap of Narayana Hrudayalaya Ltd?

Should I buy Narayana Hrudayalaya Ltd stock now?

What is the 52 week high and low of Narayana Hrudayalaya Ltd?

Is the Narayana Hrudayalaya Ltd stock good to buy?

Is Narayana Hrudayalaya Ltd a good buy for the long term?

Is Narayana Hrudayalaya Ltd overvalued or undervalued?

What is the PE and PB ratio of Narayana Hrudayalaya Ltd?

Start Now